AI assistant
IO Biotech, Inc. — Director's Dealing 2021
Nov 5, 2021
34883_dirs_2021-11-04_b5833f6b-20c0-470d-8006-1d3311897a61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04
Reporting Person: Zocca Mai-Britt (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 354 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Class A Stock | $ | Common Stock (26580) | Indirect | ||
| Warrants (Right to Buy) | $13.97 | Common Stock (8860) | Direct | ||
| Warrants (Right to Buy) | $15.36 | Common Stock (7442) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (115778) | Direct | ||
| Warrants (Right to Buy) | $19.62 | Common Stock (10525) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (94848) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (366339) | Direct |
Footnotes
F1: Upon the closing of the Issuer's initial public offering ("IPO"), each share of Class A Stock beneficially owned by the reporting person will automatically convert, for no additional consideration, into the number of shares of Common Stock reported in Column 3. These shares of Class A Stock have no expiration date.
F2: The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of his pecuniary interest therein.
F3: These Warrants vested in 25% annual increments on December 31 of each year following the November 23, 2016 grant date.
F4: Warrants expire in annual increments on the fifth anniversary of the vesting date.
F5: These Warrants vested in 25% annual increments on December 31 of each year following the February 21, 2017 grant date.
F6: These Warrants vest in 1/48 monthly increments after the May 27, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.
F7: These Warrants vest in 1/48 monthly increments after October 15, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.